Solara Active Pharma Sciences Ltd (SOLARA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003017,
    "name": "Solara Active",
    "stock_name": "Solara Active",
    "full_name": "Solara Active Pharma Sciences Ltd",
    "name_url": "stocks-analysis/solara-active",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "569.35",
    "chg": -12.65,
    "chgp": "-2.17%",
    "dir": -1,
    "prev_price": "582.00",
    "mcapval": "2,720.59 Cr",
    "mcap": "Small Cap",
    "scripcode": 541540,
    "symbol": "SOLARA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE624Z01016",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "1.07 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/solara-active-1003017-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Solara Active Pharma Sciences Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/solara-active-pharma-sciences-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3986970",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SolaraActivePha_mojoScore_3986970.png",
        "date": "2026-05-12 09:08:41",
        "description": "Solara Active Pharma Sciences Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 11 May 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite some valuation appeal, the company’s financial trends and quality metrics have raised significant concerns, prompting a reassessment of its outlook within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Solara Active Pharma Sciences Ltd Gains 1.36%: Technical Shifts and Fundamental Challenges Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/solara-active-pharma-sciences-ltd-gains-136-technical-shifts-and-fundamental-challenges-shape-the-week-3983120",
        "imagepath": "",
        "date": "2026-05-09 12:07:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Week opens at Rs.518.40</p>\n                    <p><strong>5 May:</strong> Rating upgraded to Sell on technical improvements</p>\n                    <p><strong>6 May:</strong> Technical momentum shifts amid mixed signals</p>\n                    <p><strong>8 May:</strong> Week closes at Rs.525.45 (+1.36%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.518.40</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.525.45</div><div class=\"stat-change positive\">+1.36%</div></d..."
      },
      {
        "title": "Solara Active Pharma Sciences Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/solara-active-pharma-sciences-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-3977169",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SolaraActivePha_mojoScore_3977169.png",
        "date": "2026-05-06 08:33:56",
        "description": "Solara Active Pharma Sciences Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 5 May 2026, driven primarily by an improvement in technical indicators despite persistent fundamental challenges. The company’s technical trend has shifted from mildly bearish to sideways, prompting a reassessment of its outlook. However, weak financial performance and long-term profitability concerns continue to weigh on the stock’s prospects."
      },
      {
        "title": "Solara Active Pharma Sciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/solara-active-pharma-sciences-ltd-is-rated-strong-sell-3962121",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SolaraActivePha_mojoScore_3962121.png",
        "date": "2026-04-25 10:10:25",
        "description": "Solara Active Pharma Sciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 December 2025, reflecting a reassessment of the company’s outlook. However, the analysis and financial metrics discussed here represent the stock’s current position as of 25 April 2026, providing investors with the latest insights into its performance and prospects."
      }
    ],
    "total": 15,
    "sid": "1003017",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/solara-active-pharma-sciences-1003017"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "16-Jun-2026",
      "details": "Allotment of 70000 Equity Shares pursuant to exercise of Options under Solara Employee Stock Option Plan 2024",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "16-Jun-2026",
      "details": "Allotment of 2250 Equity shares pursuant to exercise of Options under Solara Employee Stock Option Plan 2018",
      "source": "BSE"
    },
    {
      "caption": "Clarification On Volume Movement",
      "datetime": "10-Jun-2026",
      "details": "Clarification in relation to the Email received from BSE on June 10 2026 on Volume movement.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Solara Active Pharma Sciences Ltd has declared <strong>30%</strong> dividend, ex-date: 18 Aug 21",
          "dt": "2021-08-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Solara Active Pharma Sciences Ltd has announced <strong>1:3</strong> rights issue, ex-date: 15 May 24",
          "dt": "2024-05-15",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Solara Active Pharma Sciences Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals

2026-05-12 09:08:41

Solara Active Pharma Sciences Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 11 May 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite some valuation appeal, the company’s financial trends and quality metrics have raised significant concerns, prompting a reassessment of its outlook within the Pharmaceuticals & Biotechnology sector.

Solara Active Pharma Sciences Ltd Gains 1.36%: Technical Shifts and Fundamental Challenges Shape the Week

2026-05-09 12:07:08

Key Events This Week 4 May: Week opens at Rs.518.40 5 May: Rating upgraded to Sell on technical improvements 6 May: Technical momentum shifts amid mixed signals 8 May: Week closes at Rs.525.45 (+1.36%) Week OpenRs.518.40 Week CloseRs.525.45+1.36%</d...

Solara Active Pharma Sciences Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

2026-05-06 08:33:56

Solara Active Pharma Sciences Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 5 May 2026, driven primarily by an improvement in technical indicators despite persistent fundamental challenges. The company’s technical trend has shifted from mildly bearish to sideways, prompting a reassessment of its outlook. However, weak financial performance and long-term profitability concerns continue to weigh on the stock’s prospects.

Solara Active Pharma Sciences Ltd is Rated Strong Sell

2026-04-25 10:10:25

Solara Active Pharma Sciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 December 2025, reflecting a reassessment of the company’s outlook. However, the analysis and financial metrics discussed here represent the stock’s current position as of 25 April 2026, providing investors with the latest insights into its performance and prospects.

View All News